Cargando…
Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART
A 27-year-old male with HIV-associated naïve and high-risk Burkitt’s lymphoma sequentially received short-term, high-dose non-myeloablative chemotherapy and autologous CD34-positive stem cell transfusion in the setting of combined antiretroviral therapy (cART). Prompt hematopoietic recovery was obse...
Autores principales: | Min, Haiyan, Yang, Jianwei, Wang, Sanbin, Tao, Pengfei, Song, Yuqin, Wang, Xiaopei, Li, Huiqin, Yang, Xinping, Dong, Xingqi, Wang, Fu-Sheng, Shi, Ming, Wang, Xicheng, Xu, Ruonan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302511/ https://www.ncbi.nlm.nih.gov/pubmed/30572947 http://dx.doi.org/10.1186/s13287-018-1089-5 |
Ejemplares similares
-
Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV
por: Spitsin, Sergei, et al.
Publicado: (2021) -
Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)
por: Cai, Guoqing, et al.
Publicado: (2015) -
Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL
por: Yu, Changlin, et al.
Publicado: (2020) -
HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients
por: Valcour, Victor G., et al.
Publicado: (2013) -
Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults
por: Mathiesen, Inger Hee, et al.
Publicado: (2017)